Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
5(38%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
9
69%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

13

all time

Status Distribution
Active(7)
Completed(4)
Other(2)

Detailed Status

Recruiting4
Completed4
unknown2
Enrolling by invitation1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
5
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (10.0%)
N/A9 (90.0%)

Trials by Status

recruiting431%
unknown215%
enrolling_by_invitation18%
not_yet_recruiting18%
completed431%
active_not_recruiting18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
OTHER
Total Trials
13